期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (1)
Background: Long non-coding RNAs (lncRNAs) are essential indicators for hepatocellular carcinoma. LncRNAs can exert the same functions as their antise......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (2)
Background: Primary biliary cholangitis (PBC) is a complex disease with high heritability. We investigated the association between human leukocyte ant......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (7)
Background: Long non-coding RNAs (lncRNAs) are closely associated with the pathogenesis of numerous diseases including cancers. LncRNA AGAP2 Antisense......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (2)
18 F-fluorodeoxyglucose positron emission tomography/computed tomography has been used in clinical practice for many years. This modality is of great ......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (7)
Background: Pseudogenes are dysfunctional copies of protein-coding genes that showed critical regulatory roles during carcinogenesis. Plasminogen like......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (11)
Aims: To determine SNHG8's function and potential mechanisms in gastric cancer (GC) chemoresistance. Methods: We assessed SNHG8 expression in GC cell ......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (4)
Background: Optimal non-invasive biomarkers for diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD) remain to be identified. Aims: To ......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (2)
Background: Both microwave ablation and robot-assisted hepatectomy are representative minimally in-vasive treatments for early hepatocellular carcinom......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (3)
A B S T R A C T Background: No study on the relationship between hepatic steatosis and sex hormone levels in male patients with chronic hepatitis B (C......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (6)
Background and aims: Gastric cancer (GC) is a malignant tumor that seriously affects human health and Epstein-Barr virus (EBV)-associated gastric canc......
期刊: DIGESTIVE AND LIVER DISEASE, 2022; 54 (7)
Background: Hepatocellular carcinoma (HCC) is recognized as a leading cause of cancer-associated fatality worldwide. Our study here aimed to probe the......